JP2022518944A5 - - Google Patents
Info
- Publication number
- JP2022518944A5 JP2022518944A5 JP2021544351A JP2021544351A JP2022518944A5 JP 2022518944 A5 JP2022518944 A5 JP 2022518944A5 JP 2021544351 A JP2021544351 A JP 2021544351A JP 2021544351 A JP2021544351 A JP 2021544351A JP 2022518944 A5 JP2022518944 A5 JP 2022518944A5
- Authority
- JP
- Japan
- Prior art keywords
- diazaspiro
- trifluoroethoxy
- decane
- pyrimidine
- biphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798827P | 2019-01-30 | 2019-01-30 | |
| US62/798,827 | 2019-01-30 | ||
| PCT/IB2020/000074 WO2020157577A1 (en) | 2019-01-30 | 2020-01-30 | A dosage regime and method for treating pulmonary arterial hypertension with rodatristat ethyl |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022518944A JP2022518944A (ja) | 2022-03-17 |
| JP2022518944A5 true JP2022518944A5 (enExample) | 2022-12-19 |
Family
ID=70285725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544351A Pending JP2022518944A (ja) | 2019-01-30 | 2020-01-30 | 肺動脈性肺高血圧症を治療するための投与レジメンおよび方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11607413B2 (enExample) |
| EP (1) | EP3917531A1 (enExample) |
| JP (1) | JP2022518944A (enExample) |
| KR (1) | KR20210133953A (enExample) |
| CN (1) | CN113557022A (enExample) |
| AU (1) | AU2020213746A1 (enExample) |
| CA (1) | CA3128327A1 (enExample) |
| MX (1) | MX2021009055A (enExample) |
| WO (1) | WO2020157577A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3119912A1 (en) * | 2018-11-14 | 2020-05-22 | Altavant Sciences Gmbh | A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) for treating diseases or disorders associated with peripheral serotonin |
| US11413287B2 (en) * | 2018-11-16 | 2022-08-16 | Altavant Sciences Gmbh | Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| WO2020128614A1 (en) * | 2018-12-17 | 2020-06-25 | Altavant Sciences Gmbh | Method for treating interstital lung disease |
| MX2021009055A (es) | 2019-01-30 | 2021-10-22 | Altavant Sciences Gmbh | Pauta posológica y método para tratar la hipertensión arterial pulmonar con rodatristat etilo. |
| AU2020244278A1 (en) * | 2019-03-15 | 2021-09-30 | Altavant Sciences Gmbh | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing |
| WO2023062595A1 (en) | 2021-10-14 | 2023-04-20 | Altavant Sciences Gmbh | Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7875622B2 (en) | 2007-07-11 | 2011-01-25 | Lexicon Pharmaceuticals, Inc. | Methods and compositions for treating pulmonary hypertension and related diseases and disorders |
| UA119247C2 (uk) | 2013-09-06 | 2019-05-27 | РОЙВЕНТ САЙЕНСИЗ ҐмбГ | Спіроциклічні сполуки як інгібітори триптофангідроксилази |
| CA3119912A1 (en) * | 2018-11-14 | 2020-05-22 | Altavant Sciences Gmbh | A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) for treating diseases or disorders associated with peripheral serotonin |
| US11413287B2 (en) | 2018-11-16 | 2022-08-16 | Altavant Sciences Gmbh | Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| WO2020128614A1 (en) | 2018-12-17 | 2020-06-25 | Altavant Sciences Gmbh | Method for treating interstital lung disease |
| WO2020128608A1 (en) | 2018-12-17 | 2020-06-25 | Altavant Sciences Gmbh | Compound for use in a method for treating sarcoidosis-associated pulmonary hypertension |
| MX2021009055A (es) | 2019-01-30 | 2021-10-22 | Altavant Sciences Gmbh | Pauta posológica y método para tratar la hipertensión arterial pulmonar con rodatristat etilo. |
| AU2020244278A1 (en) * | 2019-03-15 | 2021-09-30 | Altavant Sciences Gmbh | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing |
-
2020
- 2020-01-30 MX MX2021009055A patent/MX2021009055A/es unknown
- 2020-01-30 KR KR1020217024232A patent/KR20210133953A/ko not_active Abandoned
- 2020-01-30 US US16/777,458 patent/US11607413B2/en active Active
- 2020-01-30 CA CA3128327A patent/CA3128327A1/en active Pending
- 2020-01-30 AU AU2020213746A patent/AU2020213746A1/en not_active Abandoned
- 2020-01-30 CN CN202080016400.5A patent/CN113557022A/zh active Pending
- 2020-01-30 JP JP2021544351A patent/JP2022518944A/ja active Pending
- 2020-01-30 EP EP20718760.0A patent/EP3917531A1/en not_active Withdrawn
- 2020-01-30 WO PCT/IB2020/000074 patent/WO2020157577A1/en not_active Ceased
-
2023
- 2023-01-25 US US18/159,494 patent/US20240041877A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022518944A5 (enExample) | ||
| US6335021B1 (en) | Composition for controlling mood disorders in healthy individuals | |
| US11045447B2 (en) | Methods for inducing synaptogenesis with synaptic growth factor activating compounds | |
| CN107519159A (zh) | 复方组合物 | |
| US20160030383A1 (en) | Low-dose doxepin for treatment of sleep disorders in elderly patients | |
| KR101951220B1 (ko) | 조합 als 치료법 | |
| EP2442832A1 (en) | Compositions and methods for treatment of multiple sclerosis | |
| RU2010109359A (ru) | Азитромицин для лечения кожных заболеваний | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| JP2010065060A (ja) | 心不全処置のための複合治療 | |
| JP2016505050A5 (enExample) | ||
| WO2020128608A1 (en) | Compound for use in a method for treating sarcoidosis-associated pulmonary hypertension | |
| AU2013362755B2 (en) | Uses and methods for the treatment of liver diseases or conditions | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| CN109172550B (zh) | 一种复合麻醉药物 | |
| CN113827590A (zh) | 右美托咪定在助眠药物制备中的应用 | |
| JP2019504040A (ja) | 中等度〜重度のインフルエンザの処置 | |
| JP2025511402A5 (enExample) | ||
| JP2025511401A5 (enExample) | ||
| TW201244732A (en) | Ezatiostat for treating multiple myeloma | |
| RU2318516C2 (ru) | Способ лечения эректильной дисфункции у мужчин | |
| EP4029503B1 (en) | Drug combinations of entecavir and a tlr7 agonist for use in the treatment of hbv | |
| AU2013301125B2 (en) | A3 adenosine receptor ligands for use in treatment of a sexual dysfunction | |
| US20190381034A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases |